Castle Biosciences, Inc. ( CSTL) - Key Metrics
CSTL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.97 | -$0.08 | $0.92 | $0.67 |
| 2025Q3 | $3.32 | -$0.02 | $0.90 | $0.31 |
| 2025Q2 | $2.98 | $0.16 | $0.72 | $0.40 |
| 2025Q1 | $3.08 | -$0.90 | -$0.21 | -$0.38 |
CSTL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -122.33 |
| 2025Q3 | ? | -284.63 |
| 2025Q2 | ? | 32.63 |
| 2025Q1 | ? | -5.54 |
CSTL
Price: $24.81
52 week price:
Earnings Per Share: -0.42 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 126500
Market Capitalization: 731.3 million